Recent News for PTGX - Protagonist Therapeutics, Inc.

Date Title
May 29 The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 28 Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences
May 28 Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
May 18 Analysts Just Made A Major Revision To Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Revenue Forecasts
May 13 The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
May 13 Protagonist Therapeutics, Inc. (PTGX) CEO Dinesh Patel on Q1 2020 Results - Earnings Call Transcript
May 12 The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
May 12 Protagonist Therapeutics prices upsized equity offering
May 12 Protagonist Therapeutics, Inc. Announces Upsizing and Pricing of Underwritten Public Offering of 7,000,000 Shares of Common Stock
May 11 Company News for May 11, 2020
May 11 Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 11 32 Stocks Moving in Monday's Pre-Market Session
May 11 Protagonist Therapeutics, Inc. Announces Proposed Underwritten Public Offering of Common Stock
May 11 3 Small-Cap Biotech Stocks That Surged Last Week
May 11 96 Biggest Movers From Friday
May 10 Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2020 Earnings Call Transcript
May 9 Edited Transcript of PTGX earnings conference call or presentation 7-May-20 9:00pm GMT
May 8 Why Did Protagonist Therapeutics (PTGX) Soar 83.7% Today?
May 8 Mid-Afternoon Market Update: Crude Oil Rises 5%; ProAssurance Shares Plummet
May 8 Why Protagonist Therapeutics Is Skyrocketing Today
May 8 70 Stocks Moving In Friday's Mid-Day Session
May 8 Mid-Day Market Update: Everspin Technologies Surges Following Q1 Results; Microvision Shares Fall
May 8 Protagonist Therapeutics: Price Over Earnings Insights
May 8 Protagonist Therapeutics extends cash runway on focused plan for lead drug
May 7 Protagonist EPS misses by $0.03, beats on revenue

Back to the Main PTGX Page...